Cite

HARVARD Citation

    Rajoli, R. et al. (2021). Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis. British journal of clinical pharmacology. 87 (4), pp. 2078-2088. [Online]. 
  
Back to record